Nov 07, 2007
Quintiles Transnational (Research Triangle Park, North Carolina) has acquired Central American CRO Bio-Trials. The purchase was made by Quintiles’ Latin American subsidiary, based in Buenos Aires, Argentina.
Nov 06, 2007
Isotechnika (Edmonton, Canada) has received permission from the US Food and Drug Administration for the long-term use of ISA247 for the prevention of rejection in patients currently participating in its Phase IIb kidney transplant (PROMISE) trial.
Nov 06, 2007
The US Food and Drug Administration has sent a warning letter to Sanofi-Aventis, detailing failings in Aventis’s oversight of investigators involved in a clinical trial of the antibiotic Ketek (telithromycin) in 2001-02.